Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Kaye

Showing results (181-190 of 411) with videos related to

Pageof 42
Sort By:
Journal of Cataract and Refractive Surgery|April 29, 1998
Validation of a handheld automated keratometer in adultsC P Noonan, G P Rao, S B Kaye, et al.
Biochemical Pharmacology|October 15, 1988
Comparative cellular uptake and cytotoxicity of a complex of daunomycin-low density lipoprotein in human squamous lung tumour cell monolayersD J Kerr, S A Hynds, J Shepherd, et al.
British Journal of Cancer|October 1, 1988
Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograftD J Kerr, A Rogerson, G J Morrison, et al.
Eye (London, England)|January 1, 1991
Reducing disinfectant wastageS B Kaye, R Graham, K McCarthy, et al.
British Journal of Cancer|October 1, 1987
Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamilS Merry, E R Courtney, C A Fetherston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2013
Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patientsJ M Flanagan, C S Wilhelm-Benartzi, M Metcalf, et al.
The British Journal of Clinical Practice|January 1, 1994
Primary meningococcal conjunctivitis in childrenC Neoh, A Agius-Fernandez, S B Kaye, et al.
Lancet (London, England)|March 9, 1991
Medical audit, cancer registration, and survival in ovarian cancerC R Gillis, D J Hole, R M Still, et al.
British Journal of Cancer|November 1, 1988
Cancer support groups--who joins and why?G Deans, G B Bennett-Emslie, J Weir, et al.
Clinical Pharmacology and Therapeutics|January 20, 2009
From darkness to light with biomarkers in early clinical trials of cancer drugsC P Carden, U Banerji, S B Kaye, et al.
Pageof 42

Showing results (181-190 of 411) with videos related to

Sort By:
Pageof 42
Journal of Cataract and Refractive Surgery|April 29, 1998
Validation of a handheld automated keratometer in adultsC P Noonan, G P Rao, S B Kaye, et al.
Biochemical Pharmacology|October 15, 1988
Comparative cellular uptake and cytotoxicity of a complex of daunomycin-low density lipoprotein in human squamous lung tumour cell monolayersD J Kerr, S A Hynds, J Shepherd, et al.
British Journal of Cancer|October 1, 1988
Antitumour activity and pharmacokinetics of niosome encapsulated adriamycin in monolayer, spheroid and xenograftD J Kerr, A Rogerson, G J Morrison, et al.
Eye (London, England)|January 1, 1991
Reducing disinfectant wastageS B Kaye, R Graham, K McCarthy, et al.
British Journal of Cancer|October 1, 1987
Circumvention of drug resistance in human non-small cell lung cancer in vitro by verapamilS Merry, E R Courtney, C A Fetherston, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2013
Association of somatic DNA methylation variability with progression-free survival and toxicity in ovarian cancer patientsJ M Flanagan, C S Wilhelm-Benartzi, M Metcalf, et al.
The British Journal of Clinical Practice|January 1, 1994
Primary meningococcal conjunctivitis in childrenC Neoh, A Agius-Fernandez, S B Kaye, et al.
Lancet (London, England)|March 9, 1991
Medical audit, cancer registration, and survival in ovarian cancerC R Gillis, D J Hole, R M Still, et al.
British Journal of Cancer|November 1, 1988
Cancer support groups--who joins and why?G Deans, G B Bennett-Emslie, J Weir, et al.
Clinical Pharmacology and Therapeutics|January 20, 2009
From darkness to light with biomarkers in early clinical trials of cancer drugsC P Carden, U Banerji, S B Kaye, et al.
Pageof 42